K M Newton

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. ncbi Learning health care systems: leading through research: the 18th Annual HMO Research Network Conference, April 29-May 2, 2012, Seattle, Washington
    Katherine M Newton
    Research and External Affairs, Group Health Research Institute, Seattle, Washington USA
    Clin Med Res 10:140-2. 2012
  2. ncbi Hormone therapy discontinuation: physician practices after the Women's Health Initiative
    Katherine M Newton
    Group Health Research Institute, Seattle, WA, USA
    Menopause 17:734-40. 2010
  3. ncbi Reprint of The Herbal Alternatives for Menopause (HALT) Study: background and study design
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue Ste 1600, Seattle, WA 98101, USA
    Maturitas 61:181-93. 2008
  4. ncbi Hormone therapy initiation after the Women's Health Initiative
    Katherine M Newton
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Menopause 15:487-93. 2008
  5. ncbi Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial
    Katherine M Newton
    Group Health Center for Health Studies, The University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98101, USA
    Ann Intern Med 145:869-79. 2006
  6. ncbi The physician's role in women's decision making about hormone replacement therapy
    K M Newton
    Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101, USA
    Obstet Gynecol 92:580-4. 1998
  7. ncbi Soy protein and bone mineral density in older men and women: a randomized trial
    K M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Maturitas 55:270-7. 2006
  8. ncbi The Herbal Alternatives for Menopause (HALT) Study: background and study design
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Maturitas 52:134-46. 2005
  9. ncbi The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    J Gen Intern Med 20:350-6. 2005
  10. ncbi Women's responses to a mailed hormone replacement therapy workbook
    K M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Menopause 8:361-7. 2001

Research Grants

  1. HRT Decision Making in the Post-WHI Era
    Katherine Newton; Fiscal Year: 2006
  2. ALTERNATIVE THERAPIES FOR MENOPAUSE: A RANDOMIZED TRIAL
    Katherine Newton; Fiscal Year: 2004

Detail Information

Publications36

  1. ncbi Learning health care systems: leading through research: the 18th Annual HMO Research Network Conference, April 29-May 2, 2012, Seattle, Washington
    Katherine M Newton
    Research and External Affairs, Group Health Research Institute, Seattle, Washington USA
    Clin Med Res 10:140-2. 2012
    ..Representatives from the NCI, NHLBI, NIMH, and PCORI met with researchers to advance the quality and breadth of public domain research in HMOs. In this article we summarize information about the HMORN and its 18th annual conference...
  2. ncbi Hormone therapy discontinuation: physician practices after the Women's Health Initiative
    Katherine M Newton
    Group Health Research Institute, Seattle, WA, USA
    Menopause 17:734-40. 2010
    ..No guidelines or randomized trials address best practices for hormone therapy (HT) discontinuation...
  3. ncbi Reprint of The Herbal Alternatives for Menopause (HALT) Study: background and study design
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue Ste 1600, Seattle, WA 98101, USA
    Maturitas 61:181-93. 2008
    ..Despite inherent challenges, the study of alternative therapies for menopause symptoms is a rewarding and important area deserving of further inquiry...
  4. ncbi Hormone therapy initiation after the Women's Health Initiative
    Katherine M Newton
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Menopause 15:487-93. 2008
    ..To describe hormone therapy (HT) initiation after the 2002 publication of the Women's Health Initiative...
  5. ncbi Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial
    Katherine M Newton
    Group Health Center for Health Studies, The University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98101, USA
    Ann Intern Med 145:869-79. 2006
    ..Herbal supplements are widely used for vasomotor symptoms...
  6. ncbi The physician's role in women's decision making about hormone replacement therapy
    K M Newton
    Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101, USA
    Obstet Gynecol 92:580-4. 1998
    ..To ascertain the sources of information women use when making decisions about hormone replacement therapy (HRT)...
  7. ncbi Soy protein and bone mineral density in older men and women: a randomized trial
    K M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Maturitas 55:270-7. 2006
    ..Test the hypothesis that soy isoflavone supplementation preserves bone mineral density (BMD) in men and women...
  8. ncbi The Herbal Alternatives for Menopause (HALT) Study: background and study design
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Maturitas 52:134-46. 2005
    ..Despite inherent challenges, the study of alternative therapies for menopause symptoms is a rewarding and important area deserving of further inquiry...
  9. ncbi The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    J Gen Intern Med 20:350-6. 2005
    ....
  10. ncbi Women's responses to a mailed hormone replacement therapy workbook
    K M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Menopause 8:361-7. 2001
    ..Although numerous decision-making tools exist, few have been evaluated. The objective of this study was to examine women's use of a workbook designed to promote informed HRT decision-making...
  11. ncbi What factors account for hormone replacement therapy prescribing frequency?
    K M Newton
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave Suite 1600, Seattle, WA 98101, USA
    Maturitas 39:1-10. 2001
    ..The purpose of this study was to compare hormone replacement therapy (HRT) prescribing frequency to provider characteristics, attitudes and beliefs about menopause and HRT...
  12. ncbi Use of alternative therapies for menopause symptoms: results of a population-based survey
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Obstet Gynecol 100:18-25. 2002
    ..To describe self-reported prevalence of the use of alternative therapies for menopause symptoms and subject characteristics associated with their use...
  13. ncbi Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Diabetes Care 26:2810-6. 2003
    ..To evaluate the association between estrogen therapy and cardiovascular disease risk among women with type 2 diabetes...
  14. ncbi A population-based study of periodontal care among those with and without diabetes
    Katherine M Newton
    Group Health Research Institute, Seattle, WA, USA
    J Periodontol 82:1650-6. 2011
    ..Our objectives were to describe the prevalence of periodontal care (a marker of periodontitis) among persons with and without diabetes and to examine the association between periodontal care and diabetes...
  15. ncbi Understanding attitudes of older women toward hormone replacement therapy
    E A Phelan
    Department of Medicine, University of Washington, Seattle, Washington, USA
    Prev Med 32:49-56. 2001
    ..Little is known about factors that may explain different attitudes...
  16. ncbi Effect of improved glycemic control on health care costs and utilization
    E H Wagner
    MacColl Institute for Healthcare Innovation, Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Suite 1290, Seattle, WA 98101, USA
    JAMA 285:182-9. 2001
    ..Because of the additional costs associated with improving diabetes management, there is interest in whether improved glycemic control leads to reductions in health care costs, and, if so, when such cost savings occur...
  17. ncbi Preeclampsia and risk of developing subsequent diabetes
    D B Carr
    Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195 6460, USA
    Hypertens Pregnancy 28:435-47. 2009
    ..Determine whether preeclampsia is associated with developing diabetes...
  18. ncbi Factors associated with non-compliance with hormone therapy cessation before screening mammography
    K M Newton
    Group Health Research Institute, Seattle, Washington State 98101, USA
    Climacteric 14:268-74. 2011
    ..To evaluate factors associated with non-compliance with discontinuation of hormone therapy (HT) within a study on the effect of HT cessation on mammography performance...
  19. ncbi Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence
    M F Fialkow
    Department of Obstetrics and Gynecology, Univ of Washington School of Medicine, Box 356460, Seattle, WA 98195, USA
    Int Urogynecol J Pelvic Floor Dysfunct 19:437-40. 2008
    ..POP and UI appear to be common problems, undoubtedly affecting an even larger proportion of the women than suggested by this high cumulative incidence of surgery...
  20. ncbi Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history
    Meira Epplein
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Epidemiol 168:563-70; discussion 571-6. 2008
    ..Whether these risk factors predispose women to cancer simply by increasing EH incidence or continue to augment cancer risk even after EH is present is currently unknown...
  21. ncbi Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study
    Susan D Reed
    Group Health Center for Health Studies, Seattle, WA, USA
    Menopause 15:51-8. 2008
    ..To evaluate vaginal, endometrial, and reproductive hormone effects of three herbal regimens compared with placebo and hormone therapy (HT)...
  22. ncbi Depressive symptoms, bone loss, and fractures in postmenopausal women
    Leslie Spangler
    Group Health Center for Health Studies, Seattle, WA, USA
    J Gen Intern Med 23:567-74. 2008
    ..Osteoporosis and depression may be associated through common physiologic systems or risk factors...
  23. ncbi Night sweats, sleep disturbance, and depression associated with diminished libido in late menopausal transition and early postmenopause: baseline data from the Herbal Alternatives for Menopause Trial (HALT)
    Susan D Reed
    Center for Health Studies, Group Health Cooperative, University of Washington School of Medicine, Seattle, WA, USA
    Am J Obstet Gynecol 196:593.e1-7; discussion 593.e7. 2007
    ..The objective of the study was to evaluate the association of depression, sleep disturbance, and menopausal symptoms with diminished libido...
  24. ncbi The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin
    Leslie Spangler
    Center for Health Studies, Group Health, Seattle, WA 98101, USA
    Maturitas 57:195-204. 2007
    ..Little is known about its effect on other physiologic parameters that could result in untoward events. This study examines the effect of black cohosh on lipids, fibrinogen, glucose and insulin...
  25. ncbi Risk factors for coronary heart disease in women
    Katherine M Newton
    Center for Health Studies Group Health Cooperative, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Nurs Clin North Am 39:145-63. 2004
    ..The focus of future research will be on clarifying the role of these factors, particularly for women and ethnic minorities...
  26. ncbi Hormone therapy prescribing patterns in the United States
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Obstet Gynecol 104:1042-50. 2004
    ....
  27. ncbi Indications for hormone therapy: the post-Women's Health Initiative era
    Susan D Reed
    Department of Obstetrics and Gynecology, University of Washington Harborview Medical Center, 325 9th Avenue, Box 359865, Seattle, WA 98115, USA
    Endocrinol Metab Clin North Am 33:691-715. 2004
    ....
  28. ncbi Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs
    Gerlof D Valk
    EMGO Institute, Amsterdam, The Netherlands
    Health Serv Res 39:709-25. 2004
    ..Although much effort was put into improving process and patient outcomes, both complex programs still showed only moderate effects...
  29. ncbi Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States
    Charlotte Atkinson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Clin Nutr 87:679-87. 2008
    ..Studies suggest beneficial health effects associated with daidzein-metabolizing phenotypes; thus, assessing their determinants is an important goal...
  30. ncbi Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus
    Darcy B Carr
    Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington 98195 6460, USA
    Diabetes Care 31:1037-9. 2008
    ..To determine whether 1-h oral glucose challenge test (OGCT) or 3-h oral glucose tolerance test (OGTT) results below gestational diabetes mellitus (GDM) criteria are associated with developing diabetes...
  31. ncbi How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes
    Terry M Bush
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    J Gen Intern Med 22:1311-6. 2007
    ....
  32. ncbi Gestational diabetes and the incidence of type 2 diabetes: a systematic review
    Catherine Kim
    Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA
    Diabetes Care 25:1862-8. 2002
    ..To examine factors associated with variation in the risk for type 2 diabetes in women with prior gestational diabetes mellitus (GDM)...
  33. ncbi Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial
    Kenneth F Adams
    Fred Hutchinson Cancer Research Center, University of Washington, Center for Health Studies, Group Health Cooperative, Seattle, WA, USA
    J Nutr 133:1316-9. 2003
    ..A 12 mo, 83 mg/d soy isoflavone intervention did not modulate serum IGF in an older, mostly male population...
  34. ncbi Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial
    Kenneth F Adams
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Am J Clin Nutr 82:620-6. 2005
    ....
  35. ncbi Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial
    Kenneth F Adams
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, MP-800, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 13:644-8. 2004
    ..6% versus 12.8%; P = 0.54). We found no evidence that a 12-month 83 mg/day isoflavone treatment alters serum PSA concentration or velocity in seemingly healthy men aged 50-80 years...
  36. ncbi The incidence of repeat uterine surgery following myomectomy
    Susan D Reed
    Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA
    J Womens Health (Larchmt) 15:1046-52. 2006
    ..To determine the incidence of subsequent leiomyoma surgery following myomectomy in a population-based cohort...

Research Grants10

  1. HRT Decision Making in the Post-WHI Era
    Katherine Newton; Fiscal Year: 2006
    ..This study will provide key information about HRT decision making, and experiences with HRT discontinuation, in an era of increased scientific clarity about HRT's risks and benefits. ..
  2. ALTERNATIVE THERAPIES FOR MENOPAUSE: A RANDOMIZED TRIAL
    Katherine Newton; Fiscal Year: 2004
    ....